CORONA
CORONA Remedies Limited
Pharmaceuticals
Share price
₹2,263
Market cap
₹13,857 Cr
1Y return
▲ 58%
Corona Remedies Limited, founded in 2004 and headquartered in Ahmedabad, is a pharmaceutical company manufacturing and distributing medicines across women's healthcare, cardiology, pain management, and urology. The company operates two manufacturing facilities in Gujarat and Himachal Pradesh, holds EU-GMP and WHO certifications, and maintains market leadership positions in multiple therapeutic segments including rank #5 in women's healthcare and pain management.
Investors holding CORONA Remedies Limited
Recent moves 19
Moves19
SBI Mutual FundNew position
SBI Mutual Fund newly disclosed a 3.57% stake in CORONA Remedies Limited, holding 21,80,360 shares.
Read more
Invesco Mutual FundIncreased
Invesco Mutual Fund increased its stake in CORONA Remedies Limited from 5.06% to 5.26%, purchasing 1,24,431 shares.
Read more
AmundiNew position
Amundi bought 3.12 lakh shares of CORONA Remedies Limited for ₹63.96 Cr at ₹2,050 apiece in a bulk deal.
Read more
SBI Mutual FundNew position
SBI Mutual Fund bought 6,80,000 shares of CORONA Remedies Limited for ₹139.40 Cr at ₹2050.00 apiece in a bulk deal.
Read more
SBI Mutual FundNew position
SBI Mutual Fund bought 8.6 lakh shares of CORONA Remedies Limited for ₹176.30 Cr at ₹2,050.00 apiece in a bulk deal.
Read more
AberdeenNew position
Aberdeen bought 2,74,132 shares of CORONA Remedies Limited for ₹47.42 Cr through a block deal at ₹1730.00 apiece.
Read more
AberdeenNew position
Aberdeen purchased 4,50,868 shares of Corona Remedies Limited for ₹78.00 Cr at ₹1730.00 apiece through a block deal.
Read more
Invesco Mutual FundNew position
Invesco Mutual Fund took a new position in CORONA Remedies Limited, acquiring 30,92,372 shares, representing a 5.06% stake. The fund crossed the 5% disclosure threshold.
Read more
HDFC Mutual FundNew position
HDFC Mutual Fund entered Corona Remedies with 25,06,683 shares, acquiring a 4.10% stake. HDFC Mutual Fund was the largest buyer in a June 17, 2026, block deal where Sepia Investments and Anchor Partners sold shares in Corona Remedies.
Read more
Invesco Mutual FundIncreased
Invesco Mutual Fund increased its stake in Corona Remedies from 4.58% to 5.06% by purchasing 2,89,017 shares for ₹50 Cr at ₹1730.00 apiece in an open-market transaction, crossing the 5% disclosure threshold.
Read more
Track the whales in CORONA Remedies Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1